US FDA Grants Expanded Approval of ELEVIDYS Gene Therapy for DMD Patients Ages 4 and Above

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Diagnostic Odyssey in ALS - Patient #3: Bulbar ALS with Frontotemporal Dementia

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Monday, April 4, 2022
Sponsor Information: 

Supported in part by a medical education grant from Mitsubishi Tanabe Pharma America

Faculty

Martina Wiedau, MD
University of California Medical Center, Los Angelas, California
Activity Overview: 

This case study will explore the diagnostic odyssey of Bulbar ALS with Frontotemporal Dementia in patient #3 (55-year-old-man-year-old-man).

Learning Objectives: 
  • Recognize clinical symptoms indicative of amyotrophic lateral sclerosis (ALS)
  • Understand risk factors and genetic causes of ALS Understand the optimal workflow for diagnosis based upon physical examination, a detailed patient history, electrodiagnostic testing, genetic testing, and a variety of additional specialized tests, as needed
  • Understand the use of the ALSFRS-R scale to evaluate functional impairment in patients with ALS
  • Diagnose ALS with increased skill and confidence, shortening the diagnostic journey of patients with ALS
  • Understand how to optimize medical management of confirmed ALS according to best practice guidelines